市場調查報告書

Lopinavir·Ritonavir的全球市場規模 - COVID-19的影響,各類型·各適應症·各地區預測:2020年∼2026年

Global Lopinavir and Ritonavir Market Size study (Impact of COVID 19 on Market Share), by Type (Tablet, Capsule, Oral solution), by Application and Regional Forecasts 2020-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 938624
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Lopinavir·Ritonavir的全球市場規模 - COVID-19的影響,各類型·各適應症·各地區預測:2020年∼2026年 Global Lopinavir and Ritonavir Market Size study (Impact of COVID 19 on Market Share), by Type (Tablet, Capsule, Oral solution), by Application and Regional Forecasts 2020-2026
出版日期: 2020年05月10日內容資訊: 英文
簡介

Lopinavir·Ritonavir,是一種抗病毒藥,可與人類免疫缺陷病毒(HIV)結合使用。

本報告提供全球Lopinavir·Ritonavir市場相關調查分析,提供市場概要,市場規模·預測,各市場區隔的市場分析,各地區的市場分析,競爭情形等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 全球Lopinavir·Ritonavir市場定義和範圍

第3章 全球Lopinavir·Ritonavir市場動態

  • Lopinavir·Ritonavir市場影響分析
    • 推動市場要素
    • 市場課題
    • 市場機會

第4章 全球Lopinavir·Ritonavir市場產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的建議與結論

第5章 全球Lopinavir·Ritonavir市場:各類型

  • 市場概述
  • 實際成果 - 潛在的分析
  • 市場估計與預測 (金額)
  • 子區隔分析
    • 錠劑
    • 膠囊
    • 口服液劑

第6章 全球Lopinavir·Ritonavir市場:各適應症

  • 市場概述
  • 實際成果 - 潛在的分析
  • 市場估計與預測 (金額)
  • 子區隔分析
    • 成人
    • 兒童 (14日以上)

第7章 全球Lopinavir·Ritonavir市場:各地區分析

  • 市場概述
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他地區

第8章 競爭資訊

  • 主要市場策略
  • 企業簡介
    • AbbVie Inc.
    • Lannett Co Inc.
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Mylan N.V.
    • Hetero DrugsETERO
    • Aurobindo Pharma Ltd.
    • Amneal Pharmaceuticals Inc.
    • Rewine Pharmaceutical

第9章 調查流程

目錄

Global Lopinavir and Ritonavir Market is valued approximately at USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2026. Lopinavir and ritonavir are antiviral drugs used in combination to treat human immunodeficiency virus (HIV). This combination of drug is used with other HIV medications to help control HIV disease. It facilitates to reduce the amount of HIV in the patient body so as immune system can work well. This drug decreases the chance of catching HIV complications (such as new infections, cancer) and enhances quality of life. The combination of this drug belongs to a class of drugs known as HIV protease inhibitors. Increasing cases of HIV patients is one of the prominent factors contributing towards the market growth. For instance, the U.S. Department of Health & Human Services has estimated that about 37.9 million people living with HIV in 2018 globally, an increase 8 million since 2010. Furthermore, the outbreak of COVID-19 and ongoing clinical trails to test the efficacy of lopinavir and ritonavir in COVID-19 treatment is likely to create significant growth opportunity in the market over the forecast period. For instance, on April 2020, researchers at the Jin Yin-Tan Hospital China, found that the combination of lopinavir-ritonavir HIV antivirals led to rapid symptom improvement in COVID-19 patients. However, unwanted health effects impede the growth of the market over the forecast period of 2020-2026.

The regional analysis of global Lopinavir and Ritonavir market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the significant region across the world in terms of market share owing to increasing government funding along with high incidences of HIV infection in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2026. Factors such as improving healthcare infrastructure, HIV epidemic would create lucrative growth prospects for the Lopinavir and Ritonavir market across Asia-Pacific region.

Major market player included in this report are:

AbbVie Inc.

Lannett Co Inc.

Hikma Pharmaceuticals

Cipla Limited

Mylan N.V.

Hetero Drugs

Aurobindo Pharma Ltd.

Amneal Pharmaceuticals Inc.

Rewine Pharmaceutical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Tablet

Capsule

Oral solution

By Application:

Adults

Children 14 days of age and older

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2016, 2017, 2018

Base year - 2019

Forecast period - 2020 to 2026

Target Audience of the Global Lopinavir and Ritonavir Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
    • 1.2.1.Lopinavir and Ritonavir Market, by Region, 2018-2026 (USD Billion)
    • 1.2.2.Lopinavir and Ritonavir Market, by Type, 2018-2026 (USD Billion)
    • 1.2.3.Lopinavir and Ritonavir Market, by Application, 2018-2026 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Lopinavir and Ritonavir Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Scope of the Study
    • 2.2.2.Industry Evolution
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Lopinavir and Ritonavir Market Dynamics

  • 3.1.Lopinavir and Ritonavir Market Impact Analysis (2018-2026)
    • 3.1.1.Market Drivers
    • 3.1.2.Market Challenges
    • 3.1.3.Market Opportunities

Chapter 4.Global Lopinavir and Ritonavir Market: Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
    • 4.1.6.Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2.PEST Analysis
    • 4.2.1.Political
    • 4.2.2.Economical
    • 4.2.3.Social
    • 4.2.4.Technological
  • 4.3.Investment Adoption Model
  • 4.4.Analyst Recommendation & Conclusion

Chapter 5.Global Lopinavir and Ritonavir Market, by Type

  • 5.1.Market Snapshot
  • 5.2.Global Lopinavir and Ritonavir Market by Type, Performance - Potential Analysis
  • 5.3.Global Lopinavir and Ritonavir Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4.Lopinavir and Ritonavir Market, Sub Segment Analysis
    • 5.4.1. Tablet
    • 5.4.2.Capsule
    • 5.4.3.Oral solution

Chapter 6.Global Lopinavir and Ritonavir Market, by Application

  • 6.1.Market Snapshot
  • 6.2.Global Lopinavir and Ritonavir Market by Application, Performance - Potential Analysis
  • 6.3.Global Lopinavir and Ritonavir Market Estimates & Forecasts by Application 2016-2026 (USD Billion)
  • 6.4.Lopinavir and Ritonavir Market, Sub Segment Analysis
    • 6.4.1. Adults
    • 6.4.2.Children 14 days of age and older

Chapter 7.Global Lopinavir and Ritonavir Market, Regional Analysis

  • 7.1.Lopinavir and Ritonavir Market, Regional Market Snapshot
  • 7.2.North America Lopinavir and Ritonavir Market
    • 7.2.1.U.S. Lopinavir and Ritonavir Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. Application breakdown estimates & forecasts, 2016-2026
    • 7.2.2.Canada Lopinavir and Ritonavir Market
  • 7.3.Europe Lopinavir and Ritonavir Market Snapshot
    • 7.3.1.U.K. Lopinavir and Ritonavir Market
    • 7.3.2.Germany Lopinavir and Ritonavir Market
    • 7.3.3.Rest of Europe Lopinavir and Ritonavir Market
  • 7.4.Asia-Pacific Lopinavir and Ritonavir Market Snapshot
    • 7.4.1.China Lopinavir and Ritonavir Market
    • 7.4.2.India Lopinavir and Ritonavir Market
    • 7.4.3.Japan Lopinavir and Ritonavir Market
    • 7.4.4.Rest of Asia Pacific Lopinavir and Ritonavir Market
  • 7.5.Latin America Lopinavir and Ritonavir Market Snapshot
    • 7.5.1.Brazil Lopinavir and Ritonavir Market
    • 7.5.2.Mexico Lopinavir and Ritonavir Market
  • 7.6.Rest of The World Lopinavir and Ritonavir Market

Chapter 8.Competitive Intelligence

  • 8.1.Top Market Strategies
  • 8.2.Company Profiles
    • 8.2.1. AbbVie Inc.
      • 8.2.1.1.Key Information
      • 8.2.1.2.Overview
      • 8.2.1.3.Financial (Subject to Data Availability)
      • 8.2.1.4.Product Summary
      • 8.2.1.5.Recent Developments
    • 8.2.2. Lannett Co Inc.
    • 8.2.3.
    • 8.2.4.Hikma Pharmaceuticals
    • 8.2.5.Cipla Limited
    • 8.2.6.Mylan N.V.
    • 8.2.7.Hetero DrugsETERO
    • 8.2.8.Aurobindo Pharma Ltd.
    • 8.2.9.Amneal Pharmaceuticals Inc.
    • 8.2.10.Rewine Pharmaceutical

Chapter 9.Research Process

  • 9.1.Research Process
    • 9.1.1.Data Mining
    • 9.1.2.Analysis
    • 9.1.3.Market Estimation
    • 9.1.4.Validation
    • 9.1.5.Publishing
  • 9.2.Research Attributes
  • 9.3.Research Assumption

LIST OF TABLES

  • TABLE 1.List of secondary sources, used in the study of global Lopinavir and Ritonavir market
  • TABLE 2.List of primary sources, used in the study of global Lopinavir and Ritonavir market
  • TABLE 3.Global Lopinavir and Ritonavir market, report scope
  • TABLE 4.Years considered for the study
  • TABLE 5.Exchange rates considered
  • TABLE 6.Global Lopinavir and Ritonavir market estimates & forecasts by region 2016-2026 (USD Billion)
  • TABLE 7.Global Lopinavir and Ritonavir market estimates & forecasts by Type 2016-2026 (USD Billion)
  • TABLE 8.Global Lopinavir and Ritonavir market estimates & forecasts by Application 2016-2026 (USD Billion)
  • TABLE 9.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 10.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 11.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 12.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 13.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 14.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 15.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 16.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 17.Global Lopinavir and Ritonavir market by segment, estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 18.Global Lopinavir and Ritonavir market by region, estimates & forecasts, 2016-2026 (USD BILLION)
  • TABLE 19.U.S. Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
  • TABLE 20.U.S. Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
  • TABLE 21.U.S. Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
  • TABLE 22.CANADA Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
  • TABLE 23.CANADA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
  • TABLE 24.Canada Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
  • TABLE 25.UK Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD BILLION)
  • TABLE 26.UK Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD BILLION)
  • TABLE 27.UK Lopinavir and Ritonavir Market Estimates & Forecasts by Segment 2016-2026 (USD BILLION)
  • TABLE 28.Germany Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 29.Germany Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 30.Germany Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 31.Roe Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 32.Roe Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 33.Roe Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 34.China Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 35.China Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 36.China Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 37.India Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 38.India Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 39.India Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 40.Japan Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 41.Japan Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 42.Japan Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 43.ROAPAC Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 44.ROAPAC Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 45.ROAPAC Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 46.Brazil Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 47.Brazil Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 48.Brazil Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 49.Mexico Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 50.Mexico Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 51.Mexico Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 52.ROLA Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 53.ROLA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 54.ROLA Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 55.ROW Lopinavir and Ritonavir market estimates & forecasts, 2016-2026 (USD Billion)
  • TABLE 56.ROW Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)
  • TABLE 57.ROW Lopinavir and Ritonavir market estimates & forecasts by segment 2016-2026 (USD Billion)

LIST OF FIGURES

  • FIG 1.Global Lopinavir and Ritonavir market, research methodology
  • FIG 2.Global Lopinavir and Ritonavir market, market estimation techniques
  • FIG 3.Global market size estimates & forecast methods
  • FIG 4.Global Lopinavir and Ritonavir market, key trends 2019
  • FIG 5.Global Lopinavir and Ritonavir market, growth prospects 2020-2026
  • FIG 6.Global Lopinavir and Ritonavir market, porters 5 force model
  • FIG 7.Global Lopinavir and Ritonavir market, pest analysis
  • FIG 8.Global Lopinavir and Ritonavir market, value chain analysis
  • FIG 9.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
  • FIG 10.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
  • FIG 11.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
  • FIG 12.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
  • FIG 13.Global Lopinavir and Ritonavir market by segment, 2016 & 2026 (USD Billion)
  • FIG 14.Global Lopinavir and Ritonavir market, regional snapshot 2016 & 2026
  • FIG 15.North America Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
  • FIG 16.Europe Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
  • FIG 17.Asia pacific Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
  • FIG 18.Latin America Lopinavir and Ritonavir market 2016 & 2026 (USD Billion)
  • FIG 19.Global Lopinavir and Ritonavir market, company market share analysis (2019)